Latest Leadership News

Region Group has maintained its FY27 earnings targets after reporting stronger occupancy, supermarket sales and leasing metrics at its annual meeting. The group has also exchanged contracts to sell three neighbourhood centres for $73.5 million as it sharpens its portfolio strategy.

Percheron Therapeutics has secured a funded path towards a Vanderbilt Health-led HMBD-002 trial in high-risk AML and MDS, while ending September with $4.875 million in cash. The biotechnology company also installed a new chief executive and began a preclinical combination study with Invion.

PWR Holdings has lifted its FY27 Aerospace and Defence revenue growth outlook to around 50% after delivering record FY26 revenue of $170.7 million. A new US$4.6 million pre-contract order and a planned Polish manufacturing site are adding momentum, although the larger defence opportunity remains subject to customer and program decisions.

Microba has secured a $2.025 million placement while cutting costs further, launching GI Navigator and advancing its proposed merger with Genetic Signatures. The funding comes as the company reports strong Australian testing growth but only about one quarter of cash cover before the raise.

Kingsrose Mining has promoted CEO Andy Caruso to managing director and added him to the board, while proposing a substantial incentive package subject to shareholder approval. The appointment formalises his leadership as the company pursues acquisitions and Scandinavian exploration.

McPherson’s chief executive and managing director Brett Charlton will step down after more than three years at the helm, with the board beginning an immediate search for his successor. Charlton will remain in the role during a six-month notice period, subject to arrangements agreed with the board.

Indiana Resources has completed drilling at Company Well and Minos, while heritage clearance unlocks the next stage at the 7km Ealbara gold anomaly. The exploration progress comes alongside a November CEO departure and an unresolved arbitration claim over US$13.05 million in Tanzania settlement proceeds.

Euroz Hartleys has appointed Alan Logan as CEO and unveiled a reshaped board as it prepares to complete the BMO transaction and focus on private wealth. Jay Hughes will return as chairman, while two current advisers will join the board as executive directors.

Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.

Shaver Shop Group Limited (ASX:SSG) delivered record FY2026 sales, gross profit and operating cash flow, but flagged a softer-than-expected start to the new financial year. Transform-U reached $18 million in sales, while supplier logistics issues and promotional timing weighed on early FY2027 trading.

Charter Hall Long WALE REIT has maintained its FY27 operating earnings and distribution guidance at 25.5 cents per security after delivering 2% FY26 growth. A cheaper, longer-dated debt platform and a $6.1 billion portfolio give the REIT more financial flexibility, although the outlook still depends on execution and property valuations.

Medical Developments International CEO Brent MacGregor is stepping down after six years, with CFO Anita James taking over as interim CEO from 15 October. The board has begun searching for a permanent successor as MacGregor prepares to return to North America.